Dr. Matthew Pollman
Institution Name:
Total Awards:
1
Award Value:
$8,000,000
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Tenaya Therapeutics, Inc. | Phase 1b Study of TN-401 in Adults with PKP2 Mutation-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) | $8,000,000 |
| Total: $8,000,000.00 |
